Management of the australianclinicaltrials.gov.au website has been transferred from NHMRC to the Commonwealth Department of Health. Disruption to site users as a consequence of this change should be minimal.
Broad Health Condition Eye
Specific Health ConditionDiseases / disorders of the eye
Trial location outside Australia
Iran, Islamic Republic Of
Korea, Republic Of
Serbia and Montenegro
Trinidad and Tobago
United States of America
Glaucoma is the most common cause of irreversible blindness in the world, affecting more than 70 million worldwide, of whom approximately 7 million are blind. The only proven treatment for glaucoma is to lower intraocular pressure (IOP). There are various treatment options for lowering IOP including medicine, laser, or surgery. More recently, new minimally invasive surgical devices and procedures have been introduced that aim to lower IOP and reduce dependence on medical therapy and/or avoid the need for invasive surgery. The International Glaucoma Surgery Registry (IGSR) is an observational, non-interventional, study of people who have undergone or are going to have a laser or surgical procedure for glaucoma. The inclusion criteria are a history of glaucoma or ocular hypertension requiring treatment with a laser or surgical procedure. The registry only collects information and does not influence the choice of treatment in any way. As part of routine clinical care, data will be collected on patients undergoing glaucoma procedures annually for 5 years or more with the goal of providing high-quality longitudinal data on outcomes, treatments patterns, quality of life, and cost-effectiveness. The IGSR aims to make a major contribution to understanding the clinical effectiveness of glaucoma procedures, as well as guiding evidence-based decision making and providing data to support future clinical trials.
Key inclusion criteria
This study will include all participants: 1. identified as having a glaucoma procedure 2. who do not opt-out of inclusion in the registry and collection of prospective and retrospective data 3. where a Waiver of Consent has been approved, retrospective data from participants who have previously undergone a glaucoma procedure and are no longer in active follow-up.
GenderBoth males and females
Key exclusion criteria
Patients who opt-out of the study or request removal of their data from the registry.
Sponsor Primary Sponsor Type: Other Collaborative groups
Primary Sponsor Name: International Glaucoma Surgery Registry
Primary Sponsor Address: 145 City Road London EC1V 1AW
Primary Sponsor Country: United Kingdom
Contact person for information and recruitmentDr
Centre for Eye Research Australia Level 7, 32 Gisborne Street East Melbourne VIC 3002 Australia International Glaucoma Surgery Registry 145 City Rd London EC1V 1AW United Kingdom
+61 3 9929 8360